Label-free blood plasma test based on surface-enhanced Raman scattering for tumor stages detection in nasopharyngeal cancer

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Lin, Duo ^a,b   Pan, Jianji ^c   Huang, Hao ^b   Chen, Guannan ^a   Qiu, Sufang ^c   Shi, Hong ^b   Chen, Weiwei ^b   Yu, Yun ^b   Feng, Shangyuan ^a   Chen, Rong ^a  

^a FUJIAN NORMAL UNIVERSITY   (China)

^b FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c FUJIAN PROVINCIAL CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GOLD; METAL NANOPARTICLE;

BLOOD; CANCER STAGING; CASE CONTROL STUDY; CHEMISTRY; DIAGNOSTIC USE; HUMAN; NASOPHARYNGEAL NEOPLASMS; PATHOLOGY; PROCEDURES; PROGNOSIS; RAMAN SPECTROMETRY; RECEIVER OPERATING CHARACTERISTIC; ULTRASTRUCTURE;

CASE-CONTROL STUDIES; GOLD; HUMANS; METAL NANOPARTICLES; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; ROC CURVE; SPECTRUM ANALYSIS, RAMAN;

EID: 84899129858     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04751     Document Type: Article

References (37)

1. Ji, X. et al. Nasopharyngeal carcinoma risk by histologic type in central China: Impact of smoking, alcohol and family history. Int. J. Cancer 129, 724-732 (2011).
2. Jemal, A. et al. Global cancer statistics. CA. Cancer. J. Clin. 61, 69-90 (2011).
3. Yoshizaki, T. et al. Current understanding and management of nasopharyngeal carcinoma. Auris Nasus Larynx 39, 137-144 (2012).
4. El-Sherbieny, E., Rashwan, H., Lubis, S. H. & Choi, V. J. Prognostic factors in patients with nasopharyngeal carcinoma treated in hospital Kuala Lumpur. Asian. Pac. J. Cancer. Prev. 12, 1739-1743 (2011).
5. Kwok, A. W. et al. Nasopharyngeal Carcinoma: a Cantonese Cumber. J. AMSA. 2, 1-20 (2013).
6. Chan, K. et al. Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program. Cancer 119, 1838-1844 (2013).
7. Teh, S. et al. Diagnostic potential of near-infrared Raman spectroscopy in the stomach: differentiating dysplasia from normal tissue. Brit. J. Cancer 98, 457-465 (2008). (Pubitemid 351161261)
8. Wang, H., Lee, A. M., Lui, H., McLean, D. I. & Zeng, H. AMethod for accurate in vivo micro-Raman spectroscopic measurements under guidance of advanced microscopy imaging. Sci. Rep. 3, 1-5 (2013).
9. Tu, Q. & Chang, C. Diagnostic applications of Raman spectroscopy. Nanomedicine 8, 545-558 (2012).
10. Teh, S. K. et al. Near-infrared Raman spectroscopy for gastric precancer diagnosis. J. Raman Spectrosc. 40, 908-914 (2009).
11. Feng, S. et al. Blood plasma surface-enhanced Raman spectroscopy for noninvasive optical detection of cervical cancer. Analyst 138, 3967-3974 (2013).
12. Feng, S. et al. Gastric cancer detection based on blood plasma surface-enhanced Raman spectroscopy excited by polarized laser light. Biosens. Bioelectron. 26, 3167-3174 (2011).
13. Srajer, J., Schwaighofer, A. & Nowak, C. Surface-enhanced Raman spectroscopy for biomedical diagnostics and imaging. Biomed. Spectrosc. Imaging. 2, 51-71 (2013).
14. Bantz, K. C. et al. Recent progress in SERS biosensing. Phys. Chem. Chem. Phys. 13, 11551-11567 (2011).
15. Vendrell, M., Maiti, K. K., Dhaliwal, K. & Chang, Y.-T. Surface-enhanced Raman scattering in cancer detection and imaging. Trends Biotechnol. 31, 249-257 (2013).
16. Wang, G. et al. Detection of the potential pancreatic cancer marker MUC4 in serum using surface-enhanced Raman scattering. Anal. Chem. 83, 2554-2561 (2011).
17. Chon, H., Lee, S., Son, S. W., Oh, C. H.&Choo, J. Highly sensitive immunoassay of lung cancer marker carcinoembryonic antigen using surface-enhanced Raman scattering of hollow gold nanospheres. Anal. Chem. 81, 3029-3034 (2009).
18. Chon, H. et al. Simultaneous immunoassay for the detection of two lung cancer markers using functionalized SERS nanoprobes. Chem. Commun. 47, 12515-12517 (2011).
19. Kim, J.-H. et al. Nanoparticle probes with surface enhanced Raman spectroscopic tags for cellular cancer targeting. Anal. Chem. 78, 6967-6973 (2006). (Pubitemid 44522550)
20. Lee, S. et al. Biological imaging of HEK293 cells expressing PLCγ1 using surfaceenhanced Raman microscopy. Anal. Chem. 79, 916-922 (2007).
21. Scaffidi, J. P., Gregas, M. K., Seewaldt, V. & Vo-Dinh, T. SERS-based plasmonic nanobiosensing in single living cells. Anal. Bioanal. Chem. 393, 1135-1141 (2009).
22. Feng, S. et al. Nasopharyngeal cancer detection based on blood plasma surfaceenhanced Raman spectroscopy and multivariate analysis. Biosens. Bioelectron. 25, 2414-2419 (2010).
23. Lin, D. et al. Colorectal cancer detection by gold nanoparticle based surfaceenhanced Raman spectroscopy of blood serum and statistical analysis. Opt. Express 19, 13565-13577 (2011).
24. Huang, Z. et al. Near-infrared Raman spectroscopy for optical diagnosis of lung cancer. Int. J. Cancer 107, 1047-1052 (2003). (Pubitemid 37429849)
25. Chan, J. W. et al. Micro-Raman spectroscopy detects individual neoplastic and normal hematopoietic cells. Biophys. J. 90, 648-656 (2006).
26. Lin, J. et al. A novel blood plasma analysis technique combining membrane electrophoresis with silver nanoparticle-based SERS spectroscopy for potential applications in noninvasive cancer detection. Nanomedicine 7, 655-663 (2011).
27. Li, Y. et al. Research on the Raman spectral character and diagnostic value of squamous cell carcinoma of oral mucosa. J. Raman Spectrosc. 41, 142-147 (2010).
28. Wang, H. et al. Depth-resolved in vivo micro-Raman spectroscopy of a murine skin tumor model reveals cancer-specific spectral biomarkers. J. Raman Spectrosc. 42, 160-166 (2011).
29. Premasiri, W., Lee, J. & Ziegler, L. Surface-Enhanced Raman Scattering of Whole Human Blood, Blood Plasma, and Red Blood Cells: Cellular Processes and Bioanalytical Sensing. J. Phys. Chem. B. 116, 9376-9386 (2012).
30. Hu, M. et al. Gold nanostructures: engineering their plasmonic properties for biomedical applications. Chem. Soc. Rev. 35, 1084-1094 (2006). (Pubitemid 44611721)
31. Kattumuri, V. et al. Agarose-stabilized gold nanoparticles for surface-enhanced Raman spectroscopic detection of DNA nucleosides. Appl. Phys. Lett. 88, 153114 (2006).
32. Bergholt, M. S. et al. Characterizing variability in in vivo Raman spectra of different anatomical locations in the upper gastrointestinal tract toward cancer detection. J. Biomed. Opt. 16, 037003-037010 (2011).
33. Ryan, K. M., Phillips, A. C. & Vousden, K. H. Regulation and function of the p53 tumor suppressor protein. Curr. Opin. Cell Biol. 13, 332-337 (2001). (Pubitemid 32429498)
34. Tsui, N. B., Ng, E. K. & Lo, Y. D. in Clinical Applications of PCR 123-134 (Springer, 2006).
35. Banki, F. et al. Plasma DNA is more reliable than carcinoembryonic antigen for diagnosis of recurrent esophageal cancer. J. Am. Coll. Surgeons. 207, 30-35 (2008).
36. Grabar, K. C., Freeman, R. G., Hommer, M. B. & Natan, M. J. Preparation and characterization of Au colloid monolayers. Anal. Chem. 67, 735-743 (1995).
37. Lin, K., Cheng, D. L. P. & Huang, Z. Optical diagnosis of laryngeal cancer using high wavenumber Raman spectroscopy. Biosens. Bioelectron. 35, 213-217 (2012).